Mitchell Diccianni

Title(s)	RECALL NON-FACULTY ACAD NEX, Pediatrics
School	Vc-health Sciences-schools
Address	9500 Gilman Drive # La Jolla CA 92093
vCard	Download vCard

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children's Oncology Group. J Immunother Cancer. 2023 02; 11(2). Erbe AK, Diccianni MB, Mody R, Naranjo A, Zhang FF, Birstler J, Kim K, Feils AS, Hung JT, London WB, Shulkin BL, Mathew V, Parisi MT, Servaes S, Asgharzadeh S, Maris JM, Park J, Yu AL, Sondel PM, Bagatell R. PMID: 36822669; PMCID: PMC9950969.

View in: PubMed Mentions: 2 Fields:
Neo Neoplasms The Therapeutics
Translation:Humans Cells
Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group. J Clin Oncol. 2022 12 10; 40(35):4107-4118. Desai AV, Gilman AL, Ozkaynak MF, Naranjo A, London WB, Tenney SC, Diccianni M, Hank JA, Parisi MT, Shulkin BL, Smith M, Moscow JA, Shimada H, Matthay KK, Cohn SL, Maris JM, Bagatell R, Sondel PM, Park JR, Yu AL. PMID: 35839426; PMCID: PMC9746736.

View in: PubMed Mentions: 8 Fields:
Neo Neoplasms
Translation:Humans
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology Group. Eur J Cancer. 2022 Sep; 172:264-275. Hingorani P, Krailo M, Buxton A, Hutson P, Sondel PM, Diccianni M, Yu A, Morris CD, Womer RB, Crompton B, Randall RL, Teot LA, DuBois SG, Janeway KA, Gorlick RG, Isakoff MS. PMID: 35809374; PMCID: PMC9631806.

View in: PubMed Mentions: 9 Fields:
Neo Neoplasms
Translation:Humans CTClinical Trials
Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032. Clin Cancer Res. 2021 04 15; 27(8):2179-2189. Yu AL, Gilman AL, Ozkaynak MF, Naranjo A, Diccianni MB, Gan J, Hank JA, Batova A, London WB, Tenney SC, Smith M, Shulkin BL, Parisi M, Matthay KK, Cohn SL, Maris JM, Bagatell R, Park JR, Sondel PM. PMID: 33504555; PMCID: PMC8046731.

View in: PubMed Mentions: 66 Fields:
Neo Neoplasms
Translation:Humans CTClinical Trials
Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO. PLoS One. 2020; 15(7):e0236115. Diccianni MB, Kempinska K, Gangoti JA, Yu AL, Sorkin LS. PMID: 32697811; PMCID: PMC7375533.

View in: PubMed Mentions: 3 Fields:
Med Medicine (General)Sci Science
Translation:Animals
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group. J Clin Oncol. 2020 07 01; 38(19):2160-2169. Mody R, Yu AL, Naranjo A, Zhang FF, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Hank JA, Felder M, Birstler J, Sondel PM, Asgharzadeh S, Glade-Bender J, Katzenstein H, Maris JM, Park JR, Bagatell R. PMID: 32343642; PMCID: PMC7325366.

View in: PubMed Mentions: 51 Fields:
Neo Neoplasms
Translation:Humans CTClinical Trials
Comparison of bead array and glass nanoreactor multi-analyte platforms for the evaluation of CNS and peripheral inflammatory markers during HIV infection. J Immunol Methods. 2019 02; 465:7-12. Anderson AM, Nguyen ML, Potter M, Rosario D, Kempinska K, Ellis RJ, Diccianni M, Letendre SL. PMID: 30468733; PMCID: PMC6456896.

View in: PubMed Mentions: 1 Fields:
All Allergy and Immunology Cli Clinical Laboratory Techniques
Translation:Humans CTClinical Trials
Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931. Front Immunol. 2018; 9:1641. Ozkaynak MF, Gilman AL, London WB, Naranjo A, Diccianni MB, Tenney SC, Smith M, Messer KS, Seeger R, Reynolds CP, Smith LM, Shulkin BL, Parisi M, Maris JM, Park JR, Sondel PM, Yu AL. PMID: 30046297; PMCID: PMC6055015.

View in: PubMed Mentions: 3 Fields:
All Allergy and Immunology
A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931. Front Immunol. 2018; 9:1355. Ozkaynak MF, Gilman AL, London WB, Naranjo A, Diccianni MB, Tenney SC, Smith M, Messer KS, Seeger R, Reynolds CP, Smith LM, Shulkin BL, Parisi M, Maris JM, Park JR, Sondel PM, Yu AL. PMID: 29967609; PMCID: PMC6016521.

View in: PubMed Mentions: 40 Fields:
All Allergy and Immunology
Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group. Clin Cancer Res. 2018 01 01; 24(1):189-196. Erbe AK, Wang W, Carmichael L, Kim K, Mendonça EA, Song Y, Hess D, Reville PK, London WB, Naranjo A, Hank JA, Diccianni MB, Reisfeld RA, Gillies SD, Matthay KK, Cohn SL, Hogarty MD, Maris JM, Park JR, Ozkaynak MF, Gilman AL, Yu AL, Sondel PM. PMID: 28972044; PMCID: PMC5754221.

View in: PubMed Mentions: 29 Fields:
Neo Neoplasms
Translation:Humans Cells
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial. Lancet Oncol. 2017 07; 18(7):946-957. Mody R, Naranjo A, Van Ryn C, Yu AL, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Sondel PM, Bender JG, Maris JM, Park JR, Bagatell R. PMID: 28549783; PMCID: PMC5527694.

View in: PubMed Mentions: 105 Fields:
Neo Neoplasms
Translation:Humans CTClinical Trials
Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma. PLoS One. 2017; 12(3):e0172632. Batova A, Altomare D, Creek KE, Naviaux RK, Wang L, Li K, Green E, Williams R, Naviaux JC, Diccianni M, Yu AL. PMID: 28296891; PMCID: PMC5351975.

View in: PubMed Mentions: 18 Fields:
Med Medicine (General)Sci Science
Translation:Humans
Erratum: renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy. J Exp Clin Cancer Res. 2014 Dec 05; 33:95. Williams RT, Yu AL, Diccianni MB, Theodorakis EA, Batova A. PMID: 25480670; PMCID: PMC4272799.

View in: PubMed Mentions: Fields:
Neo Neoplasms
High expression of CAI2, a 9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma. Cancer Res. 2014 Jul 15; 74(14):3753-63. Barnhill LM, Williams RT, Cohen O, Kim Y, Batova A, Mielke JA, Messer K, Pu M, Bao L, Yu AL, Diccianni MB. PMID: 25028366; PMCID: PMC4126165.

View in: PubMed Mentions: 22 Fields:
Neo Neoplasms
Translation:Humans Cells
Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodynia. PLoS One. 2014; 9(2):e87210. Terme M, Dorvillius M, Cochonneau D, Chaumette T, Xiao W, Diccianni MB, Barbet J, Yu AL, Paris F, Sorkin LS, Birklé S. PMID: 24520328; PMCID: PMC3919714.

View in: PubMed Mentions: 23 Fields:
Med Medicine (General)Sci Science
Translation:Humans Animals Cells
Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth. PLoS One. 2014; 9(2):e88219. Williams RT, Barnhill LM, Kuo HH, Lin WD, Batova A, Yu AL, Diccianni MB. PMID: 24505435; PMCID: PMC3914946.

View in: PubMed Mentions: 9 Fields:
Med Medicine (General)Sci Science
Translation:Humans Cells
Absence of MGST1 mRNA and protein expression in human neuroblastoma cell lines and primary tissue. Free Radic Biol Med. 2014 Apr; 69:167-71. Kelner MJ, Diccianni MB, Yu AL, Rutherford MR, Estes LA, Morgenstern R. PMID: 24486338; PMCID: PMC4010302.

View in: PubMed Mentions: 7 Fields:
Bio Biochemistry Med Medicine (General)
Translation:Humans Cells
Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy. J Exp Clin Cancer Res. 2013 Aug 20; 32:57. Williams RT, Yu AL, Diccianni MB, Theodorakis EA, Batova A. PMID: 23958461; PMCID: PMC3765946.

View in: PubMed Mentions: 20 Fields:
Neo Neoplasms
Translation:Humans Cells
microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res. 2010 Oct 15; 70(20):7841-50. Lin RJ, Lin YC, Chen J, Kuo HH, Chen YY, Diccianni MB, London WB, Chang CH, Yu AL. PMID: 20805302; PMCID: PMC4095771.

View in: PubMed Mentions: 92 Fields:
Neo Neoplasms
Translation:Humans Cells
Inactivation of SHIP1 in T-cell acute lymphoblastic leukemia due to mutation and extensive alternative splicing. Leuk Res. 2009 Nov; 33(11):1562-6. Lo TC, Barnhill LM, Kim Y, Nakae EA, Yu AL, Diccianni MB. PMID: 19473701; PMCID: PMC2735879.

View in: PubMed Mentions: 13 Fields:
Neo Neoplasms
Translation:Humans Cells
MPDA: microarray pooled DNA analyzer. BMC Bioinformatics. 2008 Apr 15; 9:196. Yang HC, Huang MC, Li LH, Lin CH, Yu AL, Diccianni MB, Wu JY, Chen YT, Fann CS. PMID: 18412951; PMCID: PMC2387178.

View in: PubMed Mentions: 10 Fields:
Com Computational Biology
Translation:Cells
EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine. Blood. 2006 Feb 01; 107(3):898-903. Batova A, Cottam H, Yu J, Diccianni MB, Carrera CJ, Yu AL. PMID: 16234352; PMCID: PMC1895892.

View in: PubMed Mentions: 8 Fields:
Hem Hematology
Translation:Humans Cells
Expression profiles and clinical relationships of ID2, CDKN1B, and CDKN2A in primary neuroblastoma. Genes Chromosomes Cancer. 2004 Dec; 41(4):297-308. Gebauer S, Yu AL, Omura-Minamisawa M, Batova A, Diccianni MB. PMID: 15390183.

View in: PubMed Mentions: 6 Fields:
Mol Molecular Biology Neo Neoplasms
Translation:Humans Cells
3-amino thioacridone inhibits DNA synthesis and induce DNA damage in T-cell acute lymphoblastic leukemia (T-ALL) in a p16-dependent manner. J Exp Ther Oncol. 2004 Oct; 4(3):223-37. Diccianni MB, Yu J, Meppelink G, de Vries M, Shao L, Gebauer S, Shih H, Roberts W, Kilcoin NP, Pullen J, Carson DA, Yu AL. PMID: 15724842.

View in: PubMed Mentions: Fields:
Dru Drug Therapy Neo Neoplasms
Translation:Humans
Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs. Leuk Res. 2002 Mar; 26(3):311-6. Broome HE, Yu AL, Diccianni M, Camitta BM, Monia BP, Dean NM. PMID: 11792421.

View in: PubMed Mentions: 8 Fields:
Neo Neoplasms
Translation:Humans Cells